Probably Genetic

Probably Genetic is a biotechnology and healthcare startup based in the United States. Founded in 2022, the company is committed to "Helping people with rare genetic diseases get answers." With over 400 million people worldwide affected by rare diseases, the startup aims to provide a solution for the half of those patients who are currently undiagnosed, half of whom are children. Using a state-of-the-art machine learning model, Probably Genetic's online Symptom Checker helps identify rare disease patients. The company then facilitates the testing process through its direct-to-consumer genetic testing service, expediting the diagnostic journey from the typical 5-7 years to a matter of weeks. Furthermore, Probably Genetic collaborates with drug developers to sponsor testing programs, enabling patients to access genetic testing at minimal or no cost. In November 2023, the company secured a $10.72M Venture Round investment. The investment underscores the confidence of the investor(s) in the startup's innovative approach to address the substantial challenge of diagnosing rare genetic diseases. Probably Genetic's efforts not only hold the potential to transform the lives of affected individuals but also align with the growing focus on precision medicine and personalized healthcare solutions in the biotechnology and healthcare industries.